JNJ · News · 20260910N
Regulatory Approval Milestones
JOHNSON & JOHNSON · 2026-09-10 · Importance 34 · Surprise 42 · In source text
Johnson & Johnson received CE Marking in Ireland for the ACUVUE OASYS MAX 2-Week reusable contact lens. The lens includes proprietary MAX technologies, including OptiBlue Light Filter and TearStable Technology. The product is expected to launch in select European markets in late 2026, but it has not yet received U.S. FDA approval for sale.
Key facts
- Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX 2-Week, a new reusable contact lens. source
- Johnson & Johnson secured CE Marking for its Acuvue Oasys MAX 2-Week contact lens which features OptiBlue Light Filter and TearStable Technology. source
- The Acuvue Oasys MAX 2-Week lens has not yet received FDA approval for sale in the U.S. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX 2-Week, a new reusable contact lens. |